Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126491361 | 12649136 | 1 | I | 20160801 | 20160812 | 20160812 | PER | US-TEVA-681957USA | TEVA | 0.00 | M | Y | 110.32000 | KG | 20160812 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126491361 | 12649136 | 1 | PS | NUVIGIL | ARMODAFINIL | 1 | Unknown | U | UNKNOWN | 21875 | |||||||||
| 126491361 | 12649136 | 2 | C | WELLBUTRIN | BUPROPION HYDROCHLORIDE | 1 | Unknown | 0 | |||||||||||
| 126491361 | 12649136 | 3 | C | PRISTIQ EXTENDED-RELEASE | DESVENLAFAXINE SUCCINATE | 1 | Unknown | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126491361 | 12649136 | 1 | Attention deficit/hyperactivity disorder |
| 126491361 | 12649136 | 2 | Attention deficit/hyperactivity disorder |
| 126491361 | 12649136 | 3 | Attention deficit/hyperactivity disorder |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126491361 | 12649136 | Gastrointestinal injury | |
| 126491361 | 12649136 | Hiatus hernia | |
| 126491361 | 12649136 | Intestinal cyst | |
| 126491361 | 12649136 | Off label use |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |